日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative study

多模式治疗后,白细胞亚群的早期恢复与不可手术的II/III期非小细胞肺癌患者的良好无进展生存期相关:一项前瞻性探索性研究

Hofer, Thomas P; Nieto, Alexander E; Käsmann, Lukas; Pelikan, Carolyn J; Taugner, Julian; Mathur, Saloni; Eze, Chukwuka; Belka, Claus; Manapov, Farkhad; Noessner, Elfriede

Immune checkpoint inhibition alters patterns of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy

免疫检查点抑制剂可改变接受放化疗治疗的不可手术的III期非小细胞肺癌患者的治疗失败模式

Taugner, Julian; Stamer, Silja; Hofstetter, Kerstin; Eze, Chukwuka; Käsmann, Lukas; Clasen, Kerstin; Hartig, Philipp; Spengler, Werner; Groß, Thorben; Manapov, Farkhad; Belka, Claus; Niyazi, Maximilian

Timing of stereotactic radiosurgery within the first-line systemic treatment in non-small cell lung cancer brain metastases: a retrospective single-center cohort study

非小细胞肺癌脑转移一线全身治疗中立体定向放射外科手术的时机选择:一项回顾性单中心队列研究

Bodensohn, Raphael; Kolorz, Anna; Reis, Jonas; Werner, Simone; Forbrig, Robert; Garny, Sylvia; Taugner, Julian; de Colle, Chiara; Belka, Claus; Manapov, Farkhad; von Baumgarten, Louisa; Niyazi, Maximilian

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

不可手术的III期非小细胞肺癌患者接受同步放化疗(伴或不伴免疫检查点抑制剂)治疗后,其首发转移模式:一项回顾性分析

Hofstetter, Kerstin; Taugner, Julian; Käsmann, Lukas; Mansoorian, Sina; Flörsch, Benedikt; Eze, Chukwuka; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Manapov, Farkhad

Metabolic patterns on [(18)F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment

不可切除的 III 期非小细胞肺癌患者接受放化疗±度伐利尤单抗维持治疗后,[(18)F]FDG PET/CT 的代谢模式

Holzgreve, Adrien; Taugner, Julian; Käsmann, Lukas; Müller, Philipp; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Winkelmann, Michael; Unterrainer, Lena M; Nieto, Alexander E; Bartenstein, Peter; Kunz, Wolfgang G; Ricke, Jens; Belka, Claus; Eze, Chukwuka; Unterrainer, Marcus; Manapov, Farkhad

Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis

完成同步放化疗±免疫检查点抑制剂治疗后,不可手术的III期非小细胞肺癌患者的治疗模式和预后:一项为期十年的单中心历史分析

Flörsch, Benedikt; Taugner, Julian; Käsmann, Lukas; Kenndoff, Saskia; Guggenberger, Julian; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Eze, Chukwuka; Manapov, Farkhad

Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study

在接受放化疗的不可手术切除的III期非小细胞肺癌患者中,同时/序贯免疫检查点抑制剂与序贯免疫检查点抑制剂的比较:一项前瞻性观察研究

Käsmann, Lukas; Eze, Chukwuka; Taugner, Julian; Nieto, Alexander; Hofstetter, Kerstin; Kröninger, Sophie; Guggenberger, Julian; Kenndoff, Saskia; Flörsch, Benedikt; Tufman, Amanda; Reinmuth, Niels; Duell, Thomas; Belka, Claus; Manapov, Farkhad

Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition

化疗放疗±免疫检查点抑制剂治疗后,残余代谢肿瘤体积在不可手术的III期非小细胞肺癌中的差异性作用

Unterrainer, Marcus; Taugner, Julian; Käsmann, Lukas; Tufman, Amanda; Reinmuth, Niels; Li, Minglun; Mittlmeier, Lena M; Bartenstein, Peter; Kunz, Wolfgang G; Ricke, Jens; Belka, Claus; Eze, Chukwuka; Manapov, Farkhad

Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study

前瞻性评估免疫学、分子遗传学、影像学和微生物学分析在接受同步放化疗后序贯度伐利尤单抗巩固治疗的不可切除III期非小细胞肺癌患者中的肿瘤反应和控制特征(PRECISION):一项前瞻性纵向生物标志物研究方案

Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jörg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus; Manapov, Farkhad

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

接受同步放化疗后接受度伐利尤单抗维持治疗的不可手术 III 期非小细胞肺癌患者的血液参数和体重纵向变化

Guggenberger, J; Kenndoff, S; Taugner, J; Käsmann, L; Flörsch, B; Belka, C; Eze, C; Manapov, F